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Abstract
Background: Obesity exerts an enormous health impact through its effect on coronary heart disease and its risk
factors. Primary care-based and community-based intensive lifestyle counseling may effectively promote weight
loss. There has been limited implementation and evaluation of these strategies, particularly the added benefit of
community-based intervention, in low-income Latino populations.
Design: The Vivamos Activos Fair Oaks project is a randomized clinical trial designed to evaluate the clinical and
cost-effectiveness of two obesity reduction lifestyle interventions: clinic-based intensive lifestyle counseling, either
alone (n = 80) or combined with community health worker support (n = 80), in comparison to usual primary care
(n = 40). Clinic-based counseling consists of 15 group and four individual lifestyle counseling sessions provided by
health educators targeting behavior change in physical activity and dietary practices. Community health worker
support includes seven home visits aimed at practical implementation of weight loss strategies within the person’s
home and neighborhood. The interventions use a framework based on Social Cognitive Theory, the
Transtheoretical Model of behavior change, and techniques from previously tested lifestyle interventions.
Application of the framework was culturally tailored based on past interventions in the same community and
elsewhere, as well as a community needs and assets assessment. The interventions include a 12-month intensive
phase followed by a 12-month maintenance phase. Participants are obese Spanish-speaking adults with at least
one cardiovascular risk factor recruited from a community health center in a low-income neighborhood of San
Mateo County, California. Follow-up assessments occur at 6, 12, and 24 months for the primary outcome of
percent change in body mass index at 24 months. Secondary outcomes include specific cardiovascular risk factors,
particularly blood pressure and fasting glucose levels.
Discussion and Conclusions: If successful, this study will provide evidence for broad implementation of obesity
interventions in minority populations and guidance about the selection of strategies involving clinic-based case
management and community-based community health worker support.
Clinical Trial Registration: ClinicalTrials.gov: NCT01242683
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Obesity-related health and economic burden
There is a pressing need for obesity management strate-
gies to address the growing prevalence of excess weight
in the U.S. With 68% of adults overweight (34%) or
obese (34%), [1-3] obesity-attributable medical costs in
the U.S. average $147 billion per year and account for
almost 10% of the total annual medical expenditures [4].
Obesity is strongly associated with higher rates of cor-
onary heart disease (CHD), stroke, and shorter life
expectancy, and CHD risk factors (e.g., diabetes and
hypertension) [5]. Three-quarters of obese Americans
have at least one CHD risk factor reversible through
weight loss [6]. Fortunately, even modest, 5-10% reduc-
tions in body weight, as opposed to achieving ideal
weight, are associated with clinically significant improve-
ments in CHD risk factors [7,8]. Persons of low socioe-
conomic status (SES) are disproportionately affected by
the CHD risk from obesity, in part, because they are less
likely to receive adequate clinical care [9,10]. Persons of
low SES also face more environmental factors associated
with obesity, such as lack of access to healthy foods,
high prevalence of high-calorie low-nutrient foods, and
limited safe places to exercise [11-15].
Benefits of lifestyle interventions
Intensive lifestyle interventions focused on nutrition and
physical activity may effectively promote lifestyle
changes that reduce weight and other CHD risk factors,
[16,17] but have often not been implemented and evalu-
ated in the low SES communities that most need them.
Convincing studies, including the Stanford Heart to
Heart Project and the Diabetes Prevention Program,
have shown efficacy of intensive individualized lifestyle
counseling for sustained weight loss and CHD risk fac-
tor reduction [18-23]. Research also shows that lifestyle
counseling in groups may be as effective for achieving
weight loss [24-26] and more economical compared to
individual counseling [25,27]. However, clinic-based life-
style interventions for weight loss may not sufficiently
address environmental barriers in low SES communities
[12-15].
Given the profound impact neighborhood characteris-
tics have on weight [28-30], clinic-based lifestyle inter-
ventions for weight loss may be enhanced by support in
the patient’s social environment. A growing body of
research suggests that community health workers
(CHWs) can connect clinic-based CHD risk manage-
ment services and the social environment for persons of
low SES [31-33]. CHWs are members of local commu-
nities who help community members utilize neighbor-
hood resources and develop community resilience.
CHWs with training in health care can provide support
to extend practical applications of primary care and
lifestyle interventions into homes and neighborhoods
and fill gaps in clinic-based programs, especially around
access to resources [32-34].
Despite growing evidence about the effectiveness of
intensive lifestyle counseling [18-23] and benefit of
CHWs for weight loss and CHD risk factor reduction
[31,32,35], few studies compare the benefit of CHW
support to clinic-based obesity-reduction interventions
[35]. Reducing the enormous clinical consequences of
obesity demands that our health care system resolutely
integrate the mission of obesity management into clinic-
based primary care and community-based programs,
particularly in low SES communities. Targeting
upstream health behaviors, such as nutrition and physi-
cal activity choices, has the potential to reduce adverse
obesity-related disease and its economic impacts.
Aims
Vivamos Activos Fair Oaks (VAFO) will evaluate the
clinical and cost-effectiveness of two lifestyle interven-
tions to reduce body weight among obese Latinos of low
SES who are patients of a county health clinic and have
additional CHD risk factors. The first intervention pro-
vides intensive group and individual lifestyle counseling
and case management for weight reduction and is pro-
vided by health educators in a primary care clinic (CM
arm). The second intervention combines the health edu-
cator intervention with CHW support for nutrition and
physical activity in participant’s home and community
(CM+CHW arm). Furthermore, the study aims to com-
pare the two interventions with usual care (UC) and
then transition the favored intervention to a sustainable
community health program. The study builds on
national model programs of successful weight loss, parti-
cularly DPP. Implementation also relies on our previous
Stanford Heart to Heart clinical trial, the primary care
services in the Fair Oaks Clinic of San Mateo, and the
community programs developed by El Concilio of San
Mateo County [23,36,37].
Methods
Study design
The VAFO is a randomized clinical trial in which obese
adults with CHD risk are randomized to one of three
study arms: UC, CM, or CM+CHW. All study proce-
dures and materials were approved by the Stanford
Institutional Review Board (IRB) and an independent
IRB serving San Mateo Medical Centers (SMMC).
Study setting
The VAFO project is set in the North Fair Oaks neigh-
borhood of San Mateo County and conducted out of
the Fair Oaks Clinic, an adult health clinic within the
SMMC system. The North Fair Oaks neighborhood is
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rounded by more affluent cities. Fair Oaks has a popula-
tion of 15,400 people, of which 69% is Latino and 50%
were born outside the U.S [38]. SMMC provides medical
service to most low-income residents of the County, but
has 35% fewer physicians per 100,000 capita than the
national average [39]. The shortage of physicians dispro-
portionately affects local Hispanics, 34% of which earn
b e l o w2 0 0 %o ft h ef e d e r a lp o v e r t yl i n ea n dr e l yo n
county health services [40]. In 2008, 57% of adult San
Mateo County residents were overweight (19% obese)
and 85% had at least one CHD risk factor [40].
The Fair Oaks neighborhood was chosen because of
the high prevalence of low-income Hispanics and a
prior partnership between our research group and key
stakeholders, including the Fair Oaks Clinic and El Con-
cilio of San Mateo County. Fair Oaks Clinic provides
primary care, mental health counseling, and social ser-
vices. El Concilio of San Mateo County, a community-
based organization, provides nutrition, physical activity,
and chronic disease management programs and trains
CHWs. In particular, El Concilio operates a diabetes
and metabolic syndrome management program in con-
junction with the Fair Oaks Clinic.
Eligibility criteria
Obese Spanish-speaking patients age 18 and older with
at least one conventional CHD risk factor (i.e. dia-
betes, elevated fasting glucose or hemoglobin A1c
levels, high blood pressure, elevated lipid levels) are
eligible to join the study. Exclusion criteria are
designed to: 1) minimize safety concerns; 2) prevent
loss to follow-up; and 3) avoid potential contamination
between study arms (Table 1).
Recruitment and screening
The target sample size for VAFO is 200 participants
randomized during a 15-month period. Participants
are recruited for screening by study staff who solicits
patients in the clinic or by referral from a primary
care provider (PCP). After obtaining PCP approval for
medical appropriateness, chart review and telephone
screening are performed to assess basic eligibility cri-
teria. Those not excluded receive formal eligibility
determination at clinical baseline visits (BV1 and
BV2) which both occur within three weeks of rando-
mization. BV1 includes assessment of biomedical elig-
ibility, administration of survey questionnaires, and
receipt of a pedometer to track physical activity. BV2
occurs seven to ten days after BV1 and includes
review of pedometer data and a fasting blood draw.
Following standard human subjects protocol, all parti-
cipants provide informed consent during the screen-
ing process.
Randomization and blinding
Participants are randomized to one of three arms
according to the ratio 1 UC: 2 CM: 2 CM+CHW. After
all BV2 data are collected, a blinded data analyst con-
firms study data completion and randomizes the partici-
pant to one of the three arms in permuted blocks
stratified by sex, BMI (30-34.9, 35-39.9, or ± 40), and
diabetes status. Follow-up data collection (6, 12, 18, and
24 months) is performed by data collectors blinded to
intervention status.
Baseline and follow-up measures and data collection
Participant time commitment for all research-related
measurements is approximately 2.5 hours at baseline
(for telephone screening, BV1, and BV2 combined),
Table 1 Participant inclusion and exclusion criteria
Inclusion criteria
1. Age 18 years or older;
2. Body mass between 30 and 55 kg/m
2;
3. One or more CHD risk factors:
a) Systolic blood pressure between 130 and 200 mmHg;
b) Diastolic blood pressure between 80 and 105 mmHg;
c) Total cholesterol > 180 mg/dL;
d) LDL cholesterol > 120 mg/dL;
e) HDL Cholesterol < 40 mg/dL;
f) Triglycerides > 150 mg/dL;
g) HbA1c between 6.0 and 11.5%;
h) Fasting plasma glucose between 95 and 400 mg/dL;
i) Diagnosis of Type 2 diabetes;
4. Residing in catchment area of the Fair Oaks Clinic and receiving
primary care at Fair Oaks Clinic.
Exclusion criteria
1. Inability to speak Spanish;
2. Unwilling to attempt weight loss;
3. Significant medical co-morbidities, including uncontrolled
metabolic disorders (e.g., thyroid, diabetes, renal, liver), unstable
heart disease, advanced heart failure, and ongoing substance
abuse;
4. Taking more than 10 prescription medications;
5. Psychiatric disorders requiring antipsychotics or multiple
medications;
6. Body weight change > 25 lbs. in the preceding 3 months;
7. Pregnant, planning to become pregnant, or lactating less than six
months;
8. Family household member already enrolled in the study;
9. Current or planned participation in a study that would limit full
participation in VAFO;
10. Refusal of home visits by study staff;
11. Resident of a long term care facility;
12. Plans to move during the study period (24 months post-
randomization);
13. Investigator discretion for clinical safety or adherence reasons (e.g.,
unstable housing,
chronic pain that impedes physical activity).
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24 month), and 45 minutes for the 18-month telephone
assessment (Table 2).
Primary and secondary outcomes
Primary hypotheses will be tested based on change in
BMI change from baseline to 24 months. Data collected
at the interim time points will help assess effects of
intensive phase of intervention (baseline to 12 months)
and intervention durability throughout the maintenance
phase (12 month to 24 months). The primary outcome
is change in BMI calculated as kg/m
2.W e i g h ti sc o l -
lected at BV1 and each follow-up clinic visit using the
average of two readings from a digital scale. Height is
collected at BV1 using the average of two readings from
a wall-mounted stadiometer. Weight and height are
both collected from participants in light indoor clothes
without shoes.
Secondary outcomes measure obesity-related biomedi-
cal cardiovascular risk factors. Plasma lipids, glucose,
hemoglobin A1c, and C-reactive protein are collected
after an overnight fast. Waist circumference is collected
with a tape measure around the waist at the midpoint
between the lowest part of the ribcage and the top of
the pelvic bone. Resting blood pressure is measured
after the patient has sat quietly with feet flat on the
floor for five minutes. Three blood pressures are
obtained on alternating arms and the mean of the sec-
ond and third readings is used in analysis.
Additional secondary outcome measures include beha-
vioral and psychosocial factors that might moderate the
intervention effect. The Obesity Related Problems Scale
is administered to understand impacts of obesity on
social beliefs and attitudes [41]. The Center for Epide-
miologic Studies-Depression Scale is administered to
assess prevalence and change in depression [42]. The 6-
item Food Security Assessment is administered to assess
use of food assistance and ability to purchase food [43].
The Pittsburgh Sleep Quality Index [44] and the
Strength of Religious Faith Questionnaire are also
Table 2 List of study measures and data collection schedule
Follow-up month
Baseline 6 12 18* 24
Clinical Measures
Height X
Weight XX X X
Waist circumference X X X
Blood pressure X X X X
Fasting blood: Total cholesterol, LDL-C, HDL-C, triglycerides, glucose, HBA1c X X X X
C-Reactive Protein X X X
Questionnaires
Physical Activity Readiness Survey X
Demographic history X
Employment, Income X X X X X
Modified BRFSS exercise questions X X X X X
Block Brief food Questionnaire X X X X
6-item food security assessment X X X X X
Depression Survey (CESD) X X X X X
Obesity Related Problems Scale X X X X X
Pittsburgh Sleep Quality Index XX
Strength of Religious Faith Questionnaire X X
Researcher designed physical activity and nutrition questions X X X X X
Smoking XX X X X
Adverse events XX X X
Medication use X X X X X
Pedometer
7 day pedometer log X X X X
Data extracted from electronic SMMC medical records system
Healthcare utilization (hospitalizations, emergency room and outpatient visits) X X X X
Medications prescribed X X X X
*18-month visit is conducted by telephone.
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study team assess neighborhood safety and social sup-
port networks.
Physical activity levels are measured at each clinical
assessment point by recording seven days of steps using
a pedometer worn by participants and by interviewer-
administered physical activity questions adapted from
the Centers for Disease Control Behavioral Risk Factor
Surveillance System [46]. Dietary intake is assessed by
administering the Block Brief Food Questionnaire [47].
Additional physical activity and dietary patterns are
assessed by administering questions designed by the
study researchers about sedentary activities, fast food
consumption, and use of neighborhood physical activity
and nutrition resources. Socio-demographic information
is collected including education level, place of birth, lan-
guage spoken at home, employment status and income.
Self-reported and medical record data on hospitaliza-
tions, emergency room and outpatient visits and pre-
scriptions are assessed for impact on medical resource
utilization.
Process measures
Reasons for joining and not joining the study are used
to evaluate recruitment techniques. Attendance of
friends and relatives at intervention visits is assessed to
evaluate inclusion of extended social networks. Self-
monitoring forms are collected to assess use of self-
regulation tools. Additionally, key informant interviews
will be conducted throughout the intervention period to
evaluate how the VAFO coordinates with other clinic
services and to refine the program for dissemination.
Interventions
Theoretical basis
The overriding theoretical framework for the interven-
tion is derived from Social Cognitive Theory (SCT) [48]
and the Transtheoretical Model (TTM) of Behavior
Change. SCT emphasizes the reciprocal determinism
between individual, environment, and behavior. TTM
recognizes that behavior change is a dynamic process
that moves through stages of readiness to change a pro-
blem or maintain positive or healthy behaviors. SCT
assumes that behavior change is more likely with
increased behavior capability, which is strengthened
through skill building and self-regulation. Equally
important are confidence in performing a given behavior
individually (self-efficacy) and with a support group (col-
lective efficacy) and expectations of favorable outcomes
(outcome expectations). The use of resources (facilita-
tion) and rewards (incentive motivation) also support
behavior change. TTM behavioral strategies emphasize
variation by stage of change including experiential pro-
cesses during initial phases of behavioral adoption and
behavioral processes during action and maintenance
behavior change [49]. Consistent with the ongoing
operation of Fair Oaks Clinic, VAFO emphasizes cul-
tural congruence by providing the intervention entirely
in Spanish via a bi-cultural staff that includes a CHW
who is a member of the Fair Oaks community.
At the first CM and ES sessions, VAFO intervention-
ists work with participants to identify their beliefs about
the value of achieving healthy weight. The interventions
emphasize that healthy weight is achievable through gra-
dual and sustained lifestyle change that prioritizes nutri-
tion and physical activity. Throughout the intervention
CM and CHW interventionists remind participants to
use fundamental outcome expectations (e.g. improved
health and energy to enjoy family) as motivation for
daily behavioral choices.
After establishing fundamental outcome expectations
and a belief in self-efficacy for weight loss, the interven-
tionists focus on knowledge and self-regulation to inte-
grate new skills into daily behavior. At each intervention
session participants learn about fundamental nutrition
and physical activity skills such as balanced diet, portion
control, diverse physical activities with a focus on walk-
ing, and shopping skills (Table 3). Application of SCT
learning concepts includes educational materials and
observing the interventionist perform activities. Addi-
tionally, group sessions employ experiential learning
techniques including: preparing healthy foods, in-session
physical activity, group problem solving and goal-setting,
and role-playing with simulated or real-life scenarios for
menu ordering, shopping, and portion sizes. CHW sup-
port sessions include the previously described techni-
ques and include practicing new skills with the CHW in
the home and community. Numerous materials are
employed for observational and experiential learning at
individual CM sessions.
CM and CHW interventionist use fundamental SCT
self-regulation concepts to help participants translate
knowledge about skills into behavior change. All inter-
vention sessions teach participants goal-setting techni-
ques for creating and maintaining specific, measurable,
and obtainable goals with equal attention to nutrition
and physical activity. Key self-monitoring techniques
used at all intervention sessions include calendars and
goals sheets to record health habits. Additionally, prior
to the second CHW session, participants take pictures
of meals and physical activities which are used to set
“photo goals” and help evaluate accomplishments over
the course of the study.
Key intervention feedback and reward techniques
include: 1) self-reflection that acknowledges negative
thoughts and counters them with positive statements;
and 2) praise and positive reflection for achieving goals.
Both interventions teach participants to prepare to
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agreements, economics, behavior relapses) by using
problem solving and goal-setting skills. Group sessions
u s ee d u c a t i o n a li n c e n t i v e ss u c ha st a k eh o m et i p s
sheets and health tools related to the session topic for
motivation (Table 3). Later group sessions assume
basic knowledge about topics from earlier sessions and
increasingly focus on techniques to overcome barriers,
maintain healthy behavior, respond to behavior relapse,
and reach health goals. CHW sessions are loosely con-
structed to allow CHWs to address a range of beha-
vioral goals, but must address several specific health
topics (Table 3).
All intervention sessions promote collective efficacy
and self-regulation by helping participants utilize social
support networks. Group sessions facilitate the develop-
ment of social support networks among group members
by encouraging interaction outside of group sessions. At
group sessions participants also develop collective effi-
cacy and social support through “virtual walking
groups.” Individual steps are converted to collective
miles traveled and used in a multi-media virtual travel
adventure “Steps through the Americas” that presents
health topics within the context of destinations in North
and South America. Additionally, group and CHW ses-
sions also promote social support by including family
members and friends in session activities.
Intervention phases and session structure
Both CM and CM+CHW interventions involve intensive
intervention (months 1-12) and maintenance (months
13-24) phases. In order to maintain focus on obesity
reduction, VAFO interventionists follow a protocol to
refer patients to other health care services (e.g., PCP,
mental health, diabetes clinic) and community resources
(e.g., health insurance programs, immigration assistance)
for issues not directly related to weight loss.
Intervention phases
The intensive phase for both interventions includes a
more intensive first six months and a less intensive sec-
ond six months. The first six months includes nine
group sessions and one individual CM session. The sec-
ond six months includes three group sessions and two
individual CM sessions. CM+CHW participants receive
three CHW sessions during the first six months and
two CHW sessions during the second six months. The
maintenance phase (months 13-24) includes three group
Table 3 Required group and community health worker support session topics
Group session topics
Session # Physical activity Nutrition Educational incentive
1 Overview of healthy nutrition Overview of exercise Pedometer
2 Eating healthy on a budget Being active at home Fruit and vegetable guide
3 Eating out and fast food Local exercise resources Water bottle
4 Portion control and measuring Hidden times for exercise Measuring cups
5 Label reading and breakfast Injury prevention and treatment Massage tool
6 Healthy drinks Building strong muscles Healthy drink ingredients
7 Mindful eating and lunch Take a deep breath and relax Muscle relaxation CD
8 Healthy fast food and dinner Exercise with friends and family Whole grain pasta
9 Eating at social events and holidays Mini holidays for exercise Food pamphlet
10 Healthier traditions and review Review and social dancing Recipe with ingredients
11 Relapse response Review and relay games Motivational letter
12-15 Review relapse response, problem solving, and goal setting Social support cards and displayable health guides
Community health worker support session topics*
Nutrition
Beverage inventory, evaluation of milk and water consumption, and goal for healthy beverages
Evaluation of fat in cooking and goal for cooking with less fat (steaming, baking, etc.)
Evaluation of fruit and vegetable consumption and goal for consuming more fruits and vegetables
Evaluation of high calorie foods and goals for reduction of high calorie food or snacking
Decision-making for shopping and meal planning
Physical activity
Chart and practice walking route (at first environmental support session)
Identify support network of friends and family members for exercise
Identify exercise locations in and around home
Select physical activity goal
Identify new physical activities to try
*Topics may be covered in any order, but must be during the intensive intervention phase.
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ticipants also receive two CHW sessions (Figure 1).
Session structure
Each group session lasts two hours and follows a similar
structure with four main components: 1) interactive ice-
breaker; 2) experiential nutrition activity; 3) experiential
physical activity; and 4) closing review and reminders.
Individual CM sessions complement group session cur-
riculum and CHW sessions by providing personal coun-
seling for weight reduction goals. Individual sessions
each last 30 minutes and include assessment of existing
goals, problem solving for barriers and relapses, goal
refinement, implementation for appropriate referrals,
and evaluation of progress towards long-term goals.
CHW sessions expand upon CM sessions with practical
implementation of health goals within the home and
community. VAFO CHWs are versed in group session
curriculum, chronic disease management, and Fair Oaks
neighborhood resources.
Participant safety
After receiving PCP approval for the intervention, parti-
cipants are screened for exclusion criteria and a Physical
Activity Readiness Questionnaire is conducted [50].
Adverse Events Screening is administered at each data
collection point to monitor for unexpected health events
and the onset of new diseases. Staff follows a referral
protocol for high blood pressure and PCPs review lab
results for out-of-range values as part of their routine
practice. Additionally, the study protocol is monitored
by two IRBs and a Data and Safety Monitoring Board
composed of two physicians and a PhD clinical trial epi-
demiologist not affiliated with any of the organizations
involved in the study.
Adherence and retention
VAFO uses four strategies to maximize participant
adherence and retention: 1) careful eligibility screening;
2) staff-participant rapport building and motivational
interviewing; 3) participant incentives at study visits; and
4) flexible scheduling. Quarterly newsletters are sent to
encourage retention and capture address changes. Prior
to dropping participants from the study, staff follows a
protocol to offer modified status options, such as com-
pleting forms by phone or collecting weight measure-
ment with a study scale at the participant’s home.
Sample size
Based on research literature and population trends in
weight-gain, we hypothesize weight loss of 6% in CM
+CHW arm and 2.5% in CM arm and weight gain of 2% in
the UC arm at 24 months post-randomization. The study
sample size provides adequate statistical power to test the
primary hypothesis that CM+CHW will show greater
reductions in BMI over 24 months than CM alone and, in
turn, either intervention will produce greater reductions
in BMI than UC. A sample size of 200 participants (80 in
CM, 80 in CM + CHW, and 40 in UC), is estimated to pro-
vide 82% power for detecting 3.5% difference in BMI
between the active treatments at alpha = 0.05 (two-sided)
while allowing for 15% missing rate for the primary out-
come. The sample size also provides greater than 79%
power to detect 4.5% or greater difference in BMI between
UC and either active treatment at alpha = 0.025.
Data analysis
The primary hypothesis is that patients managed
through the CM+CHW intervention will show greater
reductions in BMI over 24 months than those in CM.
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Figure 1 Schedule of data collection and intervention visits. All participants receive data collection visits. Case management visits are
provided to participants in the case management and case management plus community health worker arms. Home visits are provided by
community health workers to participants in the case management plus community health worker arm.
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tion-to-treat basis to assess the effects of intervention
on BMI over 24 months. A hierarchical random effects
model appropriately accounts for clustering of patients
by PCP and multiple measurements on individuals over
time. Using a randomized effects model, we will esti-
mate the effect of intervention assignment on BMI
while controlling for important covariates such as gen-
der, baseline BMI, and diabetes status. All primary and
secondary outcome analyses will use Holm’s adjustments
for multiple comparisons [51] which is more powerful
than the Bonferroni method in adjusting for all pairwise
comparisons [52] and for controlling the family-wise
error rate.
Random-effects regression models will also be used to
test secondary hypotheses: 1) Patients in CM or CM
+CHW intervention will experience reduced CHD risk
through favorable changes in obesity-related risk factors
relative to those in usual care;2 )Patients in the CM
+CHW intervention will experience smaller increases in
BMI from 12 months to 24 months than those in CM;
and 3) Change in BMI and other cardiovascular risk fac-
tors attributable to the intervention arm will be cost-
effective relative to usual primary care.
Estimation for the cost-effectiveness analysis will
include: measurement of costs, measurement of changes
in projected quality-adjusted life years, and calculation
of a cost-effectiveness ratio for each active intervention
compared to usual care. Health care costs associated
with CHD over a 10-year period will be derived based
on Framingham risk scoring [53,54] Interim analyses
will be completed from 12-month data and when 24-
month data is obtained from half of the sample, with
appropriate adjustment for sequential examination of
the data. Potential mediators (e.g., treatment adherence,
caloric intake, physical activity level) and moderators (e.
g., age, gender, country of origin, baseline mental status)
of the intervention’s effect on weight change also will be
examined. Study participants will be analyzed as rando-
mized (i.e., “intention to treat”) regardless of subsequent
intervention adherence. Alternative methods for hand-
ling missing data such as multiple imputations will be
used for missing outcome data.
Data management
The main study database uses research electronic data
capture (REDCap) software that simultaneously receives
data from multiple computers [55]. Additional databases
include: 1) Omron BiLink database for pedometer data;
3) MS Access database for qualitative recruitment data;
and 3) NutritionQuest Online database for Block Brief
Food Questionnaire data. The data security protocol
provides encryption, server-client authentication, and
off-site backups to protect patient confidentiality and
data integrity. Real-time data validation and weekly data
quality reports will reduce data errors.
Treatment fidelity
To ensure intervention fidelity, VAFO measures compli-
ance and adherence to delivery of program components,
the amount of the intervention received by participants,
and delivery quality. VAFO staff follows standardized
study protocol detailed in procedure manuals for indivi-
dual counseling sessions, group health education classes,
and home health visits. Following this protocol, VAFO
staff prepares educational materials, incentives, and
learning activities to deliver at specified visits. VAFO
staff completes visit forms to record delivery and receipt
of program components by participants. Forms and oral
feedback from interventionists are reviewed weekly for
completion. Deviation from the protocol is discussed at
least weekly with senior researchers and aions are taken
to keep in congruence with the study protocol. Prior to
conducting visits, VAFO staff practices mock sessions
and complete a training protocol with senior research-
ers. Additionally, 2% of intervention sessions are
recorded for evaluation by senior staff to ensure that
sessions are conducted according to protocol.
Discussion and Conclusions
Health consequences of the obesity epidemic make it a
primary health care priority. To this end, the USPSTF
recommends that clinicians screen adults for obesity and
offer intensive lifestyle counseling [56] However, clinical
providers have limited training in such counseling and
even greater impediments addressing social and environ-
mental factors that influence the development of obesity
[28-30]. Similarly, community-based organizations and
health promoters acting to reduce environmental barriers
are limited in their ability to respond to obesity-related
co-morbidities. Coordinated efforts between clinic and
community-based obesity interventions may be more
effective than either approach alone. The need for con-
gruent efforts is particularly important in low-income
communities that experience disproportionate health dis-
parities and environmental barriers [10]
VAFO is designed to test interventions that use inten-
sive lifestyle counseling in clinical and community set-
tings to confront obesity-related diseases and barriers in
the built environment. Clinic-based health educators
provide personal and group CM while community-based
CHWs provide direct environmental support in partici-
pants’ homes and neighborhoods. Health educators and
CHWs are both trained to use SCT, TTM, and experi-
ential learning concepts to promote healthy behaviors.
VAFO health educators and CHWs both provide basic
chronic disease management and facilitate patient utili-
zation of primary care services and community
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Page 8 of 10resources. This novel study involves collaboration
among academic, community and clinic partners with
diverse expertise addressing the obesity epidemic ran-
ging from primary care services and behavioral counsel-
ing to community-based exercise and nutrition classes
and distribution of fresh fruits and vegetables through
low-income food pantries.
Results from this study will provide valuable evidence
about the efficacy and cost-effectiveness of two beha-
vioral interventions to improve BMI, cardiovascular dis-
ease risk factors, and other psycho-social factors. VAFO
will contribute knowledge about clinic-based lifestyle
counseling and help discern the added benefit of a com-
munity-based behavioral intervention provided by
CHWs. If proven efficacious, CHW support coordinated
with clinic-based primary care CM may be a cost-
effective and culturally sensitive way to extend evidence-
based interventions for obesity reduction into low SES
communities.
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